Clinical Trials · NCT01946165
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 69
- Start date
- Oct 2013
- Locations
- 1 site, United States
- Primary endpoint
- Proportion of Participants With Pathologic Stage Less Than or Equal to ypT2N0